CA Patent

CA1333770C — Implantable, biodegradable system for releasing active substance

Assigned to Boehringer Ingelheim International GmbH · Expires 1995-01-03 · 31y expired

What this patent protects

The invention relates to biodegradable implants for releasing an active substance. The implants comprise a poly-D,L-lactide based carrier material containing the active substance and at least one additive material selected from solvents, plasticizers, pore-forming agents and low…

USPTO Abstract

The invention relates to biodegradable implants for releasing an active substance. The implants comprise a poly-D,L-lactide based carrier material containing the active substance and at least one additive material selected from solvents, plasticizers, pore-forming agents and low molecular weight polymers and may be produced with variable disintegration and active substance release rates.

Drugs covered by this patent

Patent Metadata

Patent number
CA1333770C
Jurisdiction
CA
Classification
Expires
1995-01-03
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim International GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.